Mission Newenergy (MNELF) and Codexis (CDXS) Head to Head Contrast

Mission Newenergy (OTCMKTS:MNELF) and Codexis (NASDAQ:CDXS) are both oils/energy companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Mission Newenergy and Codexis, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mission Newenergy 0 0 0 0 N/A
Codexis 0 0 4 0 3.00

Codexis has a consensus target price of $16.50, indicating a potential upside of 3.00%. Given Codexis’ higher probable upside, analysts plainly believe Codexis is more favorable than Mission Newenergy.

Earnings & Valuation

This table compares Mission Newenergy and Codexis’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Mission Newenergy N/A N/A -$156.69 million N/A N/A
Codexis $50.02 million 17.14 -$22.99 million ($0.50) -32.04

Codexis has higher revenue and earnings than Mission Newenergy.

Profitability

This table compares Mission Newenergy and Codexis’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mission Newenergy N/A N/A N/A
Codexis -29.83% -61.93% -32.42%

Institutional and Insider Ownership

77.1% of Codexis shares are owned by institutional investors. 11.4% of Codexis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Codexis beats Mission Newenergy on 6 of the 9 factors compared between the two stocks.

About Mission Newenergy

Mission NewEnergy Limited produces, refines, and sells biodiesel in Malaysia. The company was incorporated in 2005 and is headquartered in Subiaco, Australia.

About Codexis

Codexis, Inc. discovers, develops, and sells protein catalysts. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.

Receive News & Ratings for Mission Newenergy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mission Newenergy and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply